Suchergebnisse - "Beran, David"

PubPharm (9)

1

Diabetes and the WHO Model List of Essential Medicines

enthalten in: The lancet. Diabetes & endocrinology | 2022

von Beran, D. | Besançon, S. | Ewen, M. | +7

CommentOn: Lancet Diabetes Endocrinol. 2022 Jan;10(1):16-17. - PMID 34919863

2

Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria

enthalten in: Tropical medicine & international health : TM & IH | 2021

von Ozoh, O. | Eze, J. | Garba, B. | +6

3

Analogue insulin as an essential medicine : the need for more evidence and lower prices

enthalten in: The lancet. Diabetes & endocrinology | 2019

von Beran, D. | Hemmingsen, B. | Yudkin, J.

4

Access to insulin : applying the concept of security of supply to medicines

enthalten in: Bulletin of the World Health Organization | 2019

von Beran, D. | Mirza, Z. | Dong, J.

5

Noncommunicable diseases, access to essential medicines and universal health coverage

enthalten in: Global health action | 2019

von Beran, D. | Pedersen, H. | Robertson, J.

6

Availability and Affordability of Essential Medicines : Implications for Global Diabetes Treatment

enthalten in: Current diabetes reports | 2018

von Beran, D. | Ewen, M. | Lipska, K. | +2

7

Constraints and challenges in access to insulin : a global perspective

enthalten in: The lancet. Diabetes & endocrinology | 2016

von Beran, D. | Ewen, M. | Laing, R.

8

Improving global access to medicines for non-communicable diseases

enthalten in: The Lancet. Global health | 2014

von Beran, D. | Perrin, C. | Billo, N. | +1

9

Access to medicines versus access to treatment : the case of type 1 diabetes

enthalten in: Bulletin of the World Health Organization | 2008

von Beran, D. | McCabe, A. | Yudkin, J.

CommentOn: Bull World Health Organ. 2007 Apr;85(4):279-88. - PMID 17546309

1
[1]